Skip to main content
Diagnamed Holdings Corp. logo

Diagnamed Holdings Corp. — Investor Relations & Filings

Ticker · DMED ISIN · CA25245D1033 LEI · 529900UL67VSZMMIHW28 CSE Mining and quarrying
Open in API
Filings indexed 104 across all filing types
Latest filing 2026-01-27 Major Shareholding Noti…
Country CA Canada
Listing CSE DMED

About Diagnamed Holdings Corp.

https://diagnamed.com/

Diagnamed Holdings Corp. is a clean-technology company focused on the discovery and production of naturally occurring geologic, or "white," hydrogen. The company employs advanced subsurface analytics and proprietary soil-gas survey methods to locate hydrogen accumulations in favorable geological settings. Its core strategy involves utilizing clean, non-electrolytic extraction technologies, including patented electromagnetic stimulation tools, to release hydrogen from iron-rich rock formations and depleted reservoirs, minimizing environmental impact and achieving low-cost production. Diagnamed is actively developing Canada's Natural Hydrogen Corridor, with exploration programs concentrated in the Timiskaming District of Ontario and Québec, aiming to supply sustainable fuel to industrial, municipal, and transportation sectors.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Major Shareholding Notification Classification · 1% confidence The document is a 'Form 62-103F1', which is the standard regulatory form in Canada for 'Early Warning' reporting. This form is required when an investor's shareholding in a reporting issuer crosses specific thresholds (typically 10%). The content details the disposition of shares by MAG Silver Corp. in Reyna Silver Corp., including the number of shares, transaction dates, and the purpose of the transaction. This falls squarely under the definition of a 'Major Shareholding Notification'.
2026-01-27 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Audit Report / Information Classification · 1% confidence The document is a 'Form 52-109FV1', which is a Venture Issuer Basic Certificate required under Canadian securities legislation. This form serves as a certification of annual filings (financial statements and MD&A) by the CFO. Since it is a standalone regulatory certification document rather than the annual report itself, and it does not fit into the other specific categories like 'Annual Report' (10-K) or 'Management Reports' (MDA), it is best classified as a Regulatory Filing. FY 2025
2026-01-27 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Audit Report / Information Classification · 1% confidence The document is a 'Form 52-109FV1', which is a Venture Issuer Basic Certificate used for the certification of annual filings in Canada. This document is a regulatory requirement that accompanies annual financial statements to certify their accuracy and fair presentation. Since it is a standalone regulatory certification document rather than the annual report itself, and it does not fit into the other specific categories like '10-K' (which is a US-specific term) or 'AR' (which usually refers to audit reports), it is best classified as a Regulatory Filing. FY 2025
2026-01-27 English
Annual MD&A - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a detailed term sheet for a structured financial product ('Titres sous forme de billets BNC') issued by the National Bank of Canada. It outlines the specific terms, reference assets (Solactive Canada Insurance 5% AR), payout structures, risk factors, and calculation examples for investors. It is not a general regulatory announcement, nor is it a periodic financial report. It functions as a prospectus supplement or offering document for a specific financial instrument, which falls under the 'Capital/Financing Update' category as it relates to the bank's issuance of debt-linked securities.
2026-01-27 French
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is explicitly titled 'MANAGEMENT DISCUSSION AND ANALYSIS' for the year ended September 30, 2025. It provides a detailed review of the company's financial condition, results of operations, business overview, and corporate highlights. This content aligns perfectly with the definition of a Management Discussion and Analysis (MDA) report, which is a standard component of annual financial reporting where management explains the financial results and business trends.
2026-01-27 English
Audited annual financial statements – English.pdf
Capital/Financing Update Classification · 1% confidence The document is a 'Pricing Supplement' related to a 'short form base shelf prospectus' for the issuance of 'BMO Callable Equity Income Notes'. This is a financial instrument offering document detailing the terms, risks, and structure of a specific debt security (notes) linked to an index. In the context of financial filings, documents that detail the terms of a specific security offering under a shelf prospectus are classified as Capital/Financing Updates.
2026-01-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.